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Abstract
Background: Anxiety and depression are common among older people, with up to 20% reporting such symptoms,
and the prevalence increases with co-morbid chronic physical health problems. Access to treatment for anxiety and
depression in this population is poor due to a combination of factors at the level of patient, practitioner and healthcare
system.
There is evidence to suggest that older people with anxiety and/or depression may benefit both from one-to-one
interventions and group social or educational activities, which reduce loneliness, are participatory and offer some
activity. Non-traditional providers (support workers) working within third-sector (voluntary) organisations are a valuable
source of expertise within the community but are under-utilised by primary care practitioners. Such a resource could
increase access to care, and be less stigmatising and more acceptable for older people.
Methods: The study is in three phases and this paper describes the protocol for phase III, which will evaluate the
feasibility of recruiting general practices and patients into the study, and determine whether support workers can
deliver the intervention to older people with sufficient fidelity and whether this approach is acceptable to patients,
general practitioners and the third-sector providers.
Phase III of the NOTEPAD study is a randomised controlled trial (RCT) that is individually randomised. It recruited
participants from approximately six general practices in the UK. In total, 100 participants aged 65 years and over who
score 10 or more on PHQ9 or GAD7 for anxiety or depression will be recruited and randomised to the intervention
or usual general practice care. A mixed methods approach will be used and follow-up will be conducted 12 weeks
post-randomisation.
Discussion: This study will inform the design and methods of a future full-scale RCT.
Trial registration: ISRCTN, ID: ISRCTN16318986. Registered 10 November 2016. The ISRCTN registration is in line with the
World Health Organization Trial Registration Data Set. The present paper represents the original version of the protocol.
Any changes to the protocol will be communicated to ISRCTN.
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Background
Anxiety and depression are prevalent among older
people, with up to 20% reporting symptoms of depres-
sion [1, 2]. Demographic changes mean that even if
prevalence rates were to remain stable, the growing
numbers of older people will translate into large in-
creases in the demand for treatment for these disorders
in this population [3]. This will place an increasing bur-
den on health and social care.
Untreated anxiety and depression lead to increased
use of health and social care services, and raised mortal-
ity [4]. Depression and anxiety are more prevalent in
people with long-term physical conditions. The preva-
lence of depression in people with diabetes may be as
high as 30% [5], and the prevalence of anxiety in people
with chronic obstructive pulmonary disease is up to 25%
[6]. Depression is more than seven times more common
in those with two or more chronic physical conditions
[5]. Thus, mental and physical health problems tend to
become entwined and manifest in complex co-morbidity
[7]. As co-morbidities are common in later life (36% of
people aged 65–74 and 47% of those aged 75 and over
have a limiting chronic illness), they constitute a serious
risk factor for developing depression and/or anxiety.
Treatment of depression has the potential to improve
outcomes for diabetes [7] and to improve mortality from
all causes in older adults [8].
Depression and anxiety in older people are poorly de-
tected and managed in primary care [9]. This is particu-
larly the case in people with chronic physical ill health
problems [10]. One impediment to detection is that
older people may not present to their general practi-
tioner (GP) with depression because of the stigma they
perceive about mental health problems [11, 12]. In
addition, older people express a preference for talking
treatments rather than antidepressants [13].
A one-to-one intervention for older people with de-
pression may be insufficient. According to a systematic
review of interventions for isolated and depressed older
people [14], nine of the ten effective interventions in-
cluded were group activities with an educational or sup-
port input, whereas six of the eight ineffective
interventions provided one-to-one social support, advice
and information, or a health-needs assessment. There is
a body of evidence demonstrating the beneficial effects
of social connectedness on psychological and physical
well-being [15–17]. Indeed, a meta-analysis [15] showed
that stronger social relationships were associated with
longer life expectancy and the magnitude of the effect
was comparable to ceasing smoking, and it exceeded
that for obesity, high blood pressure and physical in-
activity (the random effects weighted average effect size
had an odds ratio of 1.50 with a 95% confidence interval
of 1.42 to 1.59), indicating a 50% increased likelihood of
survival for participants with stronger social relation-
ships. Forsman’s systematic review [18] suggests that
meaningful social activities, tailored to the older individ-
ual’s abilities and preferences, should be considered in
aiming to improve mental health and well-being among
older people. A further argument for increasing social
participation is that loneliness and depression are
strongly associated in older people [19, 20] and loneli-
ness is an independent risk factor for depression [21].
Evidence from the United States [22] suggests that for
lonely older people, there is a potential benefit from
group social or educational activities. Thus, it is reason-
able to postulate that group activity might be a useful
adjunct to treatment for mild to moderate depression.
Wicke et al. [23] demonstrate that social support influ-
ences health-related quality of life and that this associ-
ation is strongly mediated by depressive mood, and they
suggest that interventions for patients with depression
and multi-morbidities should address social dimensions.
Further evidence from a systematic review of social in-
terventions targeting loneliness in older people [24] sug-
gests that the most successful interventions for
loneliness, measured by improvement in the domains of
physical, mental and social health, tend to be group
based, participatory and offering some activity [25–27].
Such community-based interventions have been shown
to have additional benefits in terms of social inclusion
and social cohesion [28–30]. Despite the growing call for
a diverse range of support for older people, there re-
mains a paucity of evidence on what works best in
reaching those who are most vulnerable [31] and it is
clear that better designed studies, and in particular ran-
domised controlled trials (RCTs), are needed to improve
the evidence base [24].
Behavioural activation (BA) (a short-term intervention
based on cognitive behavioural therapy) is a talking
treatment known to be effective in the management of
depression [32, 33]. BA focuses on activity scheduling to
encourage participants to engage in activities that they
may have previously enjoyed but are currently avoiding.
In addition, it helps participants to develop new activ-
ities that can accommodate changes in life circum-
stances such as losses (e.g. spousal bereavement). Also,
BA encourages participants to be aware of the presence
and effects of cognitive processes (e.g. rumination) that
may serve to reinforce avoidance and/or lack of engage-
ment. Participants are, thus, supported to refocus on
their goals and valued directions in life. The main advan-
tage of BA-oriented interventions over traditional cogni-
tive behavioural therapy for depression is that it may be
easier to train non-clinical staff in it [34]. In addition,
behavioural therapies have been shown to be effective in
older people [35, 36]. BA forms the cornerstone of a
number of recent trials where the intervention is
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delivered by psychological well-being practitioners.
Richards et al. [37] found that the intervention for adults
of all ages, within a collaborative care model, was
effective.
Rationale
The study is in three phases and phases I and II have been
completed. In phase I, we synthesised existing guidelines,
results from an updated systematic review and results from
new empirical qualitative research findings. This synthesis
enabled us to refine our BA psychosocial intervention. It is
designed for older people with anxiety and/or depression
and will be deliverable by third-sector support workers. In
phase II, we assessed the feasibility of recruiting and train-
ing third-sector practitioners (support workers) to deliver
the intervention.
Methods
Aims
The aims of phase III of the study are (1) to determine if
it is feasible to recruit and randomise patients, (2) to
pilot procedures and (3) to conduct a process evaluation
to provide essential information and data to inform a
proposal for a full randomised trial.
The objectives are
1. To assess feasibility in terms of recruitment of GPs
and participants, retention and delivery of the
intervention
2. To assess the acceptability of the intervention to
participants, support workers and GPs
3. To assess questionnaire completion rates (both
arms) and non-compliance with the intervention
Design and setting
The SPIRIT (Standard Protocol Items for Randomised
Trials) recommendations were followed in preparing this
protocol (see Additional file 1). This is an individually
randomised feasibility study identifying approximately
100 eligible participants from at least six general prac-
tices in North Staffordshire, UK.
General practices are eligible to take part if they use
the clinical operating system EMIS Web. This is a clin-
ical electronic computer system for delivering health-
care, which allows healthcare professionals to record,
share and use vital patient information. The general
practices will be recruited through the Clinical Research
Network: West Midlands of the National Institute for
Health Research (NIHR). Practice recruitment will be
staggered, beginning with searches and a mail to poten-
tial participants from two practices, before we gradually
increase the number of practices as necessary. The par-
ticipation of general practices will be formalised through
written service level agreements.
Sample size
As this is not a hypothesis testing trial, a formal power
calculation is not required. Nonetheless, as this is a
feasibility study, each arm will consist of 30–40 partici-
pants to estimate reliably process outcomes relating to
recruitment, retention and attrition rates to inform a
fully powered RCT [38]. We anticipate that the total
combined loss to follow-up will not exceed 20% at 4
months and therefore, we aim to recruit 50 participants
to each treatment arm (Fig. 1).
We aim to recruit up to six practices to enable us to
recruit the required number of participants. Approxi-
mately 1000 people over 65 are expected to be registered
in an average-sized general practice of 5000 patients. On
the assumption that 50% will respond to the postal
screening questionnaire, of which we expect 20% will
have anxiety and/or depression, we anticipate a potential
sample size of 100 per practice. Of these, 30% might be
expected to give consent to take part, resulting in an an-
ticipated recruitment of approximately 30 participants
per practice over a 9-month period. Confirming these
screening and enrolment rates is part of the reason for
performing the study.
Participants
Practice lists from the general practices will be searched
by research facilitators in the clinical research network
for people aged over 65 years. GPs will screen the result-
ing lists and be asked to remove people who, as far as
they are aware, meet our exclusion criteria.
Our exclusion criteria are:
 People who are actively suicidal or harming
themselves
 People under the care of secondary or specialist
mental health services
 People currently misusing alcohol or other
substances
 People in the palliative phase of an illness
 People lacking the capacity to consent
 People unable to understand or read English
 People living in a care home
The resulting potential participants will be sent an in-
vitation pack consisting of an invitation letter, a partici-
pant information sheet, a postal screening questionnaire
with a consent to contact form and a stamped addressed
envelope (Fig. 2).
The postal screening questionnaire consists of the Patient
Health Questionnaire (PHQ9) [39] and the Generalised
Anxiety Disorder (GAD7) scale [40] and a section seeking
consent for further contact. Individuals returning a com-
pleted questionnaire with a score of 10 or higher on either
the PHQ9 or the GAD7 and who consent to further
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contact will form the sample for invitation into the
feasibility study. A research nurse will contact these in-
dividuals and re-complete the PHQ9 and GAD7 over
the phone to ensure their depression and anxiety symp-
toms are not transient. For those who score 10 or
higher on either the PHQ9 and/or the GAD7, the re-
search nurse will arrange a home visit for a baseline as-
sessment. Those who score 9 or lower on both PHQ9
and GAD7 will be informed by the nurse at the time,
over the telephone, that they are not eligible for the
study and if they wish, they will be sent a copy of a re-
source directory of local social activity groups.
If no response to the postal screening questionnaire is
received after 14 days, a reminder postcard will be sent to
participants.
Recruitment to the NOTEPAD trial
At the baseline home visit, the research nurse and potential
participant will discuss the study further. Prior to the initial
mail, the patients were screened against the exclusion criteria
by their GP, but the research nurse will check the inclusion
and exclusion criteria again and will also administer an as-
sessment of cognitive capacity using a cognitive capacity
Fig. 1 NOTEPAD CONSORT flow chart
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proforma. If the participant has impaired cognitive capacity,
they will not be recruited to the study.
From those eligible, the research nurse will explain what
participating in the study will involve, i.e. the completion of
baseline and follow-up questionnaires, and if randomised to
the intervention arm, participation in up to six consultations
with an Age UK support worker, a qualitative interview (sub-
sample only) and audio recording of up to two consultations
with the Age UK support worker.
Randomisation
Once written informed consent and the baseline measures
have been collected, participants will be randomised by
the Keele Clinical Trials Unit (CTU) study administrator
to either the intervention arm or the usual GP care arm,
using third-party computerised randomisation supported
by CTU. After the baseline visit, the research nurse will
contact the study administrator, who will randomise the
participant using a study-specific database. A researcher
will inform those allocated to the usual care group of the
outcome by telephone. If a participant is randomised to
the intervention arm, they will receive a letter informing
them that an Age UK support worker will make contact
with them in the next week. The participant’s contact de-
tails will be sent to the Age UK support worker by safe
haven fax.
Randomisation will be in a 1:1 ratio, using randomly
permuted blocks of sizes 4, 6 and 8, to ensure a balanced
allocation to each arm of the trial. The study statistician
and the study team members involved in the collection
of follow-up data will be blinded. Each participant’s GP
will be sent a letter informing them of their patient’s
participation and randomisation allocation.
Allocation concealment, blinding and selection bias
A clinical research network nurse blind to subsequent
treatment allocation will obtain informed consent. Selec-
tion bias at recruitment will be avoided by separating
the processes of determining patient eligibility and inter-
vention allocation. The trial database will be password
protected to ensure that the trial statistician and study
personnel involved in the questionnaire data collection
remain blind to treatment allocation. Data entry, coding,
security, storage and management will follow the stand-
ard operating procedures at Keele CTU.
The intervention
Participants in the intervention arm will be offered an
individual appointment with the Age UK support worker
at a local third-sector service or in the participant’s
home (depending on preference). It is likely that the
intervention will be more acceptable if delivered in the
participant’s own home [41]. There will be 4–6 contacts
Fig. 2 NOTEPAD: schedule of enrolment, interventions and assessments
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between the participant and the support worker, utilising
a combination of face-to-face and telephone contact.
The components of the intervention include person-
centred assessment and engagement, problem definition,
risk assessment, mood monitoring, BA (a structured
programme for reducing the frequency of negatively re-
inforced avoidant behaviours in parallel with increasing
the frequency of positively reinforcing behaviours to im-
prove functioning and improve mood) and signposting
to local agencies and activities. If during treatment it be-
comes apparent that symptoms are not improving, the
case manager and participant will collaboratively discuss
options for further treatment. This may require referral
back to the GP for possible medication review or a pre-
scription or stepping up into the local Improving Access
to Psychological Therapies service.
The intervention is intended to be tailored to patient
preference so there is some flexibility regarding the pre-
cise number of sessions, interval, mode of delivery and
format. Participant preference for the type of session will
be explored in the qualitative process outcome inter-
views. The content of the intervention will be monitored
for fidelity by audio recording the first two sessions a
support worker has with each participant. These audio
recordings will be transcribed and checked against a
fidelity checklist as part of the process evaluation. Inter-
vention group participants will also receive treatment as
usual from their primary care team.
The participants and support workers will be asked to
record basic information about participation activities. De-
tails or referrals, signposting or accompanying participants
to third-sector services will be recorded as part of the sup-
port worker role. The support worker will complete a brief
summary of the content of each participant contact. We
will ask the participants to record a one-line summary of
their sessions with the support worker and activities that
they attended (or been signposted to, but not attended).
Our Patient and Public Involvement and Engagement
(PPIE) group have helped identify how best to collect such
data and the result has been the production of an A5
Filofax-style patient resource, which includes depression
and anxiety information with example stories; a section to
keep notes on the weekly sessions; a local resource direc-
tory, which is to be populated by the support worker with
relevant information about activities in the local area; tips
on staying well and relaxation; and a useful contacts
section.
Usual care
Participants randomised to the usual care arm will re-
ceive whatever care is judged to be indicated by the pri-
mary care practitioners in contact with them. We will
use the feasibility study to describe care for participants
in the usual care arm of the study. Data on self-reported
health and social care utilisation will be collected at the
4-month follow-up. No constraints will be placed on
what constitutes usual care. At the follow-up, partici-
pants in the usual care arm will be offered a list of local
community groups, which they may choose to access.
Development of the support worker training
The support worker training programme was delivered
over 3 days by members of the research team and this
included: the aims of the study, an overview of anxiety
and depression in older people, principles of BA and
how to deliver the intervention. Role play with simulated
patients enabled the support workers to practise their
skills. The training programme was augmented with a
support worker handbook containing the training mate-
rials and supplementary background information.
Six support workers plus one reserve were trained to
deliver the intervention and the training took place in a
group setting over 3 days.
Supervision of the support workers
The support workers will be supervised to ensure safe
practice and adequate management of risk. In addition,
they will meet informally as a group at least every 2
months to facilitate peer support.
Outcomes
To achieve the aims and objectives set out for this study,
we have taken a mixed methods approach, which in-
cludes validated measures at baseline and follow-up; a
process evaluation consisting of semi-structured inter-
views with study participants, GPs and support workers;
and audio recordings of the support worker consulta-
tions. These methods of data collection will help inform
the design and methods of a future full-scale RCT and
we can examine the feasibility, acceptability and fidelity
of the support worker intervention.
Feasibility, acceptability and fidelity will be assessed
using the measures below:
1. Engagement of general practices will be measured by
recording the number of general practices that agree
to participate of those approached.
2. Recruitment, training and retention of support
workers will be measured by monitoring how many
support workers undergo full training and are
retained to the end of the study.
3. Response rates to the screening questionnaire will be
measured by recording the number of target
participants that respond to screening as a
percentage of the number mailed and invited to
participate in the study.
4. Participant recruitment rate will be measured by the
number of eligible participants who consent to
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participate in the study as a percentage of all eligible
participants.
5. Response rates to the follow-up questionnaire will
be measured recording the number of participants
who consent to participate that remain in the study
until the end of follow-up at 4 months
6. Adherence to intervention will be measured by
reviewing support worker notes at 4 months,
recording of sessions and qualitative interviews with
support workers and a sample of participants
The Computerised Clinical Interview Schedule Revised
(CIS-R) [42] total score, administered via laptop, will be
our primary clinical outcome at baseline and 4 months,
but its performance will be examined in the pilot study
in terms of its precision (based on the 95% confidence
interval), completion rate at the item and scale level, and
any evidence of floor or ceiling effects.
Secondary outcome measures include:
 General health questions
 Self-efficacy [43] (for those who disclose a long-term
condition)
 Health-related quality of life (EQ-5D-5 L) [44]
 Quality of life (Control, Autonomy, Self-realisation
and Pleasure or CASP-12) [45]
Loneliness [46]
 Adult attitude to loneliness1 [47, 48]
 Social participation questionnaire [49]
 Participant burden: The level of burden will be
monitored by free text, which will be analysed as
part of the process evaluation and the optimum
method of administration determined to help inform
the methods of the full trial.
Quantitative data
The analysis will follow a detailed statistical analysis plan
formally agreed with the study steering committee prior
to data analysis. The analysis will focus on: (i) describing
the key process measures to decide if a main trial is feas-
ible, (ii) a baseline description of the study sample, (iii)
exploratory analysis of clinical outcomes, (iv) reports of
adverse events in any of the treatment arms, (v) descrip-
tive summaries of the contacts made with the support
worker (in relation to adherence with randomised inter-
vention) and satisfaction with care and (vi) extent of
missing data and data accuracy. There will be no em-
phasis on hypothesis testing, which is reserved for the
future main trial. Feasibility outcomes will be estimated
using descriptive statistics (with 95% confidence inter-
vals). The assessment of key process measures will in-
clude determining the engagement of general practices;
recruitment, training and retention of support workers;
response rate to the screening questionnaire; and
participant recruitment uptake and response to follow-
up. Key baseline characteristics (age, gender and index
of multiple deprivation) will be compared between trial
participants and the ineligible and non-consenting pa-
tients, to ascertain the adequacy of inclusion and exclu-
sion criteria and likely generalisability of the trial to the
required targeted population. Similarly, at the 4-month
follow-up, we will compare the key patient characteris-
tics between those followed up and those lost to follow-
up and investigate how similar this is across the treat-
ment arms to assess possible attrition bias in data collec-
tion. The rate of protocol adherence will be reported
within the intervention group in terms of participants
who adhere to the intervention they were allocated to
receive or comply with the scheduled visits.
A baseline table will compare (descriptively) the demo-
graphic and key clinical characteristics between the two
trial arms. The primary clinical outcome measure at 4
months will be analysed on an intention-to-treat basis
(participants analysed according to the arm to which they
were randomised, irrespective of whether they actually re-
ceived the intervention as intended) using a linear regres-
sion model adjusted for baseline outcome scores, age and
gender to estimate the likely range of intervention effects,
i.e. to determine if the mean total CIS-R score differs be-
tween the intervention and the usual care arms after con-
trolling for the differences at baseline. The emphasis will
be on confidence intervals of effect size estimations, rather
than hypothesis testing to explore the imprecision around
effect sizes. Mixed-effect ordered logistic regression
models adjusted for age and gender will be used to com-
pare the individual symptoms on the CIS-R between the
trial arms. Scores on each of the 14 symptom groups on
the CIS-R will be entered into the models as ordinal
dependent variables. We will also analyse between-group
differences in secondary outcomes at 4 months and pro-
vide point and 95% interval estimates from linear or logis-
tic regression models as appropriate to the outcome data
being analysed (linear for numerical measures and logistic
for categorical measures). A descriptive assessment of re-
source use stratified by treatment arm will also be
presented.
Qualitative data
A process evaluation will be conducted and the data
generated will be essential to planning a future definitive
RCT. We will assess what the strengths, weaknesses and
areas for improvement are in the feasibility study. To as-
sess the acceptability of the intervention to participants,
we will conduct up to 20 semi-structured interviews
(data will be collected until category saturation is
achieved) with participants in the intervention group
shortly after the 4-month follow-up. We will also request
interviews with those who drop out of the study. These
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interviews will be conducted by the qualitative re-
searcher. We will sample on baseline characteristics to
ensure views from a diverse sample are sought.
Participants will be interviewed to determine their
overall perspectives of the intervention with a particular
emphasis on how acceptable useful they found the ses-
sions with the support worker. We will ask whether par-
ticipants attended any groups, and how acceptable and
useful they found them. We will also explore barriers
and facilitators to their (non-)engagement with the sup-
port worker or with groups and determine whether their
engagement in a group has continued.
The views of GPs will also be gathered as part of the
process evaluation. We will interview up to 12 GPs from
the participating practices. GPs will be reimbursed for
their time. We will explore GPs’ views and experiences
of the intervention and whether it has affected their
management of older people with anxiety and/or depres-
sion. We will ask the GPs for their views on the roles
and contributions of the third sector in supporting this
population, including barriers and facilitators to working
with that sector.
We will interview the six support workers who partici-
pated in the training and delivered the intervention. We
will explore their overall views and experiences of work-
ing with older people with depression and/or anxiety
and how the intervention helped or did not help. We
will ask them about their experiences of the training and
supervision, and liaison with primary care if this took
place. Interviews will be conducted at a venue and time
convenient to the participants and are expected to last
around 45 min.
Semi-structured interviews will be transcribed verba-
tim, the transcripts forming the data for analysis. The
data will be stored and analysed using the NVivo soft-
ware. Initially the data will be analysed using the con-
stant comparison method, which is the principal
technique in the grounded theory approach [50]. The
data will then be presented using the principles of
framework analysis [51], as this method is appropriate
for applied policy research and the data will allow us to
understand how the intervention was implemented by
support workers and received by participants. A team of
multi-disciplinary researchers will conduct the analysis
individually, and then agree themes through discussion.
The results of the free-text participant burden question
in the baseline and follow-up questionnaires will also be
collated and analysed using a framework approach.
Fidelity
A sample of the support worker–study participant consulta-
tions will be digitally audio recorded. Each support worker
trained (n = 6) to deliver the intervention will be asked to
record a total of two consultations with each participant
(ideally the first and second consultations). A digital recorder
will be used by the support worker at the start of the consult-
ation. Fully informed consent from the participant for the re-
cording of both consultations with the support worker will
be obtained beforehand by a member of the study team. The
use of these audio recordings will focus on the fidelity of the
intervention delivery, for example which elements of this
intervention the support workers used, whether the training
was implemented by support workers and whether there are
any gaps in intervention delivery.
Study success criteria
To determine feasibility, findings will be assessed against
the following criteria:
 Engage general practices: at least six practices to
participate.
 Recruit, train and retain support workers: at least
four support workers to be retained.
 High response rates to the screening questionnaire:
receive useable responses from at least 40% of those
mailed.
 High response rates to the follow-up questionnaire:
at least 75% for the primary outcome using minimal
data collection.
 Adherence to intervention: data to be drawn from
support worker notes and recordings of sessions. Each
participant will have at least one contact with a
support worker. This will be investigated in more
detail with the in-depth qualitative interviews with the
participants, support workers and GPs to determine
barriers and facilitators to delivering/receiving the
intervention.
 Acceptability of the intervention: to be determined
from qualitative interview data.
We will also analyse the results of the free-text partici-
pant burden question in the baseline and follow-up
questionnaires. This will help us to determine the ac-
ceptability and feasibility of the questionnaires.
Monitoring and safety considerations
The NOTEPAD feasibility trial will be monitored in line
with the protocol and Keele CTU standard operating
procedures. An independent trial steering committee
will monitor the progress of the trial and a data moni-
toring committee will be convened to monitor the safety
of the participants and data integrity. Monitoring will
also be undertaken by the research ethics committee
and the funder in the format of annual progress reports.
A serious adverse event (SAE), as defined by the NHS
Health Research Authority, that occurs for a study par-
ticipant must be reported to the research ethics commit-
tee if, in the opinion of the principal investigator, the
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event resulted from administration of the intervention
(it was related to the study) and it was unexpected.
All participants remain under the care of their GP
throughout the study. We will ask all participating GPs
to report SAEs within 24 h of becoming aware of these.
Reporting procedures will be made clear during general
practice initiation sessions and will be built into site ser-
vice level agreements, copies of which will be available
within a local site file held at every participating practice.
All participants will also be provided with the contact
details of the study coordinator and asked to self-report
any such events to the NOTEPAD team as soon as pos-
sible. Participants randomised to the NOTEPAD inter-
vention will see or speak to the support worker during
the intervention. Therefore, we will also ask the support
workers to ask about, record and report any potential
participant SAEs they become aware of to the team.
A risk protocol has been created for this study should
participants express thoughts of suicide or self-harm. Re-
searchers and support workers must initiate the suicide
ideation protocol whenever a study participant expresses
thoughts of suicide or self-harm. In such cases, the re-
searcher or support worker, with the study participant’s
permission, will inform the study participant’s GP and no-
tify the clinical investigator (or nominated deputy).
We will use our standard risk protocol to deal with
distress in participants, along with de-briefing, support
and supervision of researchers.
Patient and public involvement and engagement
The study’s design and processes have been informed by
PPIE according to INVOLVE’s recommendations (http://
www.invo.org.uk/resource-centre/resource-for-researchers/).
Participants at our initial meeting endorsed the concept of a
non-medicalised approach to the management of depression
and anxiety in older people, and welcomed partnering third-
sector groups such as Age UK. PPIE members also sup-
ported the idea of a one-to-one intervention delivered by a
worker from Age UK. We also sought comments on the full
application at a further meeting. Members of the group felt
that most older people would be happy to talk to the support
worker and strongly supported the idea of tailoring activities
to the older person’s interests, which is an important part of
our strategy. Many felt that some older people might need
some gentle encouragement and reassurance to take part.
They also felt strongly that barriers to participation, such as
transport and lack of confidence, need to be addressed. Both
points are at the heart of the intervention.
In subsequent meetings, our PPIE Group provided
strong input on our patient information sheets, letters
and patient resources. The group approved the NOTE-
PAD logo and suggested the strapline ‘Supporting
Mental Strength’, which we adopted.
Discussion
The proposed project is a feasibility study determining
whether it is possible to train third-sector workers to deliver
a psychosocial intervention to depressed and/or anxious
older people and whether this is acceptable to patients.
The target population (older people with anxiety and/
or depression) means that this study is of strategic im-
portance to the NHS and social care, and given the
existing evidence and changes in demography, has the
potential to have a significant impact on many people
across the UK. By including the public, service users, the
voluntary sector and clinicians in its development, the
proposed intervention will likely have a high degree of
acceptability and validity, and the findings of any defini-
tive trial will have a higher probability of being commis-
sioned than might otherwise be the case.
This study will inform a definitive multi-centre RCT,
which has the potential to contribute to an innovative
reorganisation of existing resources across health and
social care, including the third or voluntary sector, and
more effectively target resources to early intervention, to
prevent the deterioration of mental health symptoms in
older people.
Dissemination
The results of this study will be reported to the trial steering
committee, data monitoring committee and our funder, pub-
lished in relevant high-quality peer-reviewed journals and
presented at both national and international conferences.
Trial status
Screening for potentially eligible participants commenced in
January 2017. Recruitment has completed. The follow-up
for this study is due to be completed in August 2017.
Endnotes
1The Adult Attitude to Loneliness is not yet a validated
measure. It was adapted from the Adult Attitude for Grief
and it will be used in this feasibility study to gather data
on the acceptability of the scale to NOTEPAD participants
and to the research nurse who administers it.
Additional file
Additional file 1: SPIRIT 2013 Checklist. Recommended items to address
in a clinical trial protocol and related documents. (DOC 122 kb)
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